Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
Regulation of MCP function by QPCTL and DPP4 a, Glutaminyl cyclase
2.3.2.5: glutaminyl-peptide cyclotransferase - BRENDA Enzyme Database
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases - ScienceDirect
Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library
An overview of glutaminyl cyclase inhibitors for Alzheimer's disease
Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect
PDF) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
Full article: A patent review of glutaminyl cyclase inhibitors (2004–present)
PDF) Functions of glutaminyl cyclase and its isoform in diseases
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
_(Disc_1)-1532533638.jpg)
